In This Section
Judy Lieberman, MD, PhD

Judy Lieberman, MD, PhD

Harvard Medical School
Boston, Massachusetts

Class of 2023

Scientific Area of Expertise: Cytotoxic T lymphocytes, Innate immunity, Noncoding RNA Structure and Function

For fundamental research contributions to the field of cancer immunology that have contributed to understanding cytotoxic T lymphocytes, key effector cells in antitumor immunity; for the discovery of T-cell exhaustion in humans; and for innovative work describing the molecular basis of inflammatory cell death (pyroptosis) that is immunogenic and may be exploited to enhance antitumor immunity.